The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas.
 
Ryan Thomas Merrell
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - Anheart Therapeutics; AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Celularity; Chimerix; Day One Biopharmaceuticals; Genenta Science; GlaxoSmithKline; Insightec; Kintara Therapeutics; Merck; Mundipharma; Mundipharma; Novartis; Novocure; Novocure; Prelude Therapeutics; Prelude Therapeutics; Sagimet Biosciences; Sapience Therapeutics; Servier; Servier; SymBio Pharmaceuticals; Tango Therapeutics; Telix Pharmaceuticals; VBI Vaccines
Research Funding - AstraZeneca (Inst); Bayer (Inst); Black Damond (Inst); Chimerix (Inst); Erasca, Inc (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Quadriga Biosciences (Inst); Servier (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Deborah Anne Forst
Stock and Other Ownership Interests - Lilly
 
Jessica Schulte
Consulting or Advisory Role - Alexion (Astra Zeneca); SpringWorks Therapeutics
Research Funding - Chimerix; VBI Vaccines
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Istari; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Novocure (Inst)
(OPTIONAL) Uncompensated Relationships - Actuate Therapeutics; Chimerix
 
Daniela Annenelie Bota
Honoraria - Epitopoietic Research Corporation
 
Francisco Diaz-Mitoma
Employment - VBI Vaccines
Leadership - VBI Vaccines
Stock and Other Ownership Interests - VBI Vaccines
 
David E Anderson
Employment - VBI Vaccines
Leadership - VBI Vaccines
Stock and Other Ownership Interests - VBI Vaccines
Patents, Royalties, Other Intellectual Property - As Chief Scientific Officer at VBI Vaccines, I am an inventor on much of the company's patent, including that of VBI-1901 (the subject of submitted abstract).
Travel, Accommodations, Expenses - VBI Vaccines
 
Andrew B. Lassman
Honoraria - Clinical Education Alliance
Consulting or Advisory Role - Affinia Therapeutics; BioClinica; Global Coalition for Adaptive Research; Leal Therapeutics; Orbus Therapeutics; RadMD as an expert blinded independent reviewer of clinical and imaging data for a Roche-sponsored trial; Sapience Therapeutics; Servier
Research Funding - Abbott Laboratories (Inst); Abbvie (Inst); Aeterna Zentaris (Inst); Bayer (Inst); Biohaven Pharmaceuticals (Inst); BMS (Inst); Chimerix (Inst); Corden (Inst); DelMar Pharmaceuticals (Inst); Genentech/Roche (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Kintara Therapeutics (Inst); NextSource (Inst); Novartis (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Polaris (Inst); QED Therapeutics (Inst); Servier (Inst); VBI Vaccines (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Anheart Therapeutics; Bridgebio; Chimerix; Foundation Medicine; Gilead Sciences; Global Coalition for Adaptive Research; Helsinn Healthcare; Servier; VBI Vaccines
 
Fabio Massaiti Iwamoto
Stock and Other Ownership Interests - Praesidia Biotherapeutics
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Anheart Therapeutics; ClearView Healthcare Partners; Gennao Bio; Guidepoint Global; Kiyatec; Massive Bio; Medtronic; Merck; MimiVax; Novocure; Ono Pharmaceutical; PPD; Praesidia Biotherapeutics; Regeneron; tocagen; Xcures
Speakers' Bureau - Prime Oncology
Research Funding - ABM (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); FORMA Therapeutics (Inst); Merck (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Pfizer (Inst); Sapience Therapeutics (Inst); tocagen (Inst)
Travel, Accommodations, Expenses - Oncoceutics
(OPTIONAL) Uncompensated Relationships - Northwest Biotherapeutics